Novo Nordisk has announced an expansion of its utilization of AWS artificial intelligence tools in drug discovery, encompassing AI agents for target identification, therapy design, and...
GSK and Relation Therapeutics Collaborate in AI-Assisted Drug Discovery GSK has partnered with British biotechnology company Relation Therapeutics in a research collaboration valued at up to...
Insilico Medicine: Revolutionizing Drug Development with AI Insilico Medicine, under the leadership of CEO Alex Zhavoronkov, has successfully combined artificial intelligence with laboratory research in China...
Bristol Myers Squibb has announced the acquisition of an Nvidia DGX SuperPOD based on the chipmaker’s Vera Rubin architecture. The purpose of this purchase is to...
AWS GraphRAG Accelerates Drug Research and Development Cycles A recent deployment of AWS GraphRAG has revolutionized drug research and development cycles in pharmaceutical environments by reducing...
Insilico Medicine, a pioneer in AI-driven drug discovery, has reached a significant milestone by advancing to Phase III human trials for a drug targeting idiopathic pulmonary...
In a strategic partnership, Takeda has joined forces with Insilico Medicine, based in Hong Kong, to leverage artificial intelligence (AI) in the initial stages of drug...
The Dark Web Drug Trafficker Darren Hughes Sentenced to Over 26 Years in Federal Prison Recently, a California man, Darren Hughes, was handed a hefty prison...
Key Points to Remember Law enforcement closely monitors Interstate 80 (I-80) in Nebraska for suspected drug trafficking activities. Understanding your rights during a drug stop is...
Exciva, a biopharmaceutical company based in Heidelberg, has successfully closed a Series B funding round, raising €51 million ($59 million). The round was co-led by Gimv...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.